Open access
Jul 2026
Electrochemical Vertical Flow Immunoassay for Fast and Decentralized Determination of Stroke-Related Biomarker Glial Fibrillary Acidic Protein.
An electrochemical vertical flow immunoassay (eVFIA) as a point-of-care device for the on-site determination of GFAP demonstrates strong potential for deployment in decentralized healthcare environments, providing clinicians with a rapid and reliable tool for early stroke assessment.
P. Rioboó-Legaspi, C. Álvarez-Álvarez, Ava Takenaka et al.
· ACS Sensors · 0 citations